Acadia Healthcare (ACHC) Q3 2026 Earnings Call Transcript

Acadia Healthcare (ACHC) reported Q3 2026 revenue of $895.3M, up 5.1% YoY, driven by patient volume growth and higher revenue per patient day. Adjusted EBITDA rose 2% to $176.4M, while adjusted EPS fell to $0.60 from $0.72. The company raised full-year revenue and EBITDA guidance, citing strong demand for behavioral health services. Management noted challenges from NY Medicaid changes and a tight labor market.

Original reporting
Published Nov 5, 2026, 7:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Acadia Healthcare (ACHC) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ACHCBullishHigh
01

Why it matters

The earnings beat and raised guidance provide a fresh catalyst for short‑term price appreciation, though Medicaid headwinds and startup facility losses temper upside.

02

Market read

First‑report earnings with improved guidance create actionable trading opportunity for ACHC and may influence peer healthcare stocks.

03

What to watch

New York Medicaid changes and incremental EBITDA targets could pressure margins.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Acadia Healthcare (ACHC) reported Q3 2026 results, highlighting revenue growth, bed expansion, and revised FY guidance.

Company-level read

Ticker impact

$ACHCBullishHigh confidence
Context

Q3 2026 earnings released with revenue up 5.1% YoY and full-year guidance raised.

Expected impact

likely upward pressure as investors price in higher full-year revenue and EBITDA guidance

Evidence & confidence

Revenue rose to $895.3M, adjusted EPS $0.60, and guidance for FY revenue $3.44‑$3.46B and EBITDA $615‑$625M were increased.

Market effects

Behavioral health sector may see broader optimism from Acadia's guidance lift.

U.S. healthcare stocks could benefit from the positive earnings surprise.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

Higher guidance may already be priced in; focus on Medicaid headwinds and startup losses.

Key entities

  • Acadia Healthcare Company, Inc.

    U.S. behavioral health services provider (NASDAQ: ACHC).

Related articles

HighAI 8/10

5 revealing analyst questions from Acadia Healthcare’s Q3 2026 earnings call

Acadia Healthcare reported Q3 2026 revenue of $895.3M, beating estimates by 2%, and raised full-year guidance. Adjusted EPS of $0.60 beat estimates by 29.2%, with full-year guidance increased by 14.8%. Analysts discussed growth opportunities, capital expenditures, and Medicaid impacts during the earnings call. According to the company, operational discipline and cost controls are key for future improvement.

$ACHCMedAI 8/10

Acadia Healthcare Q3 Earnings Call Highlights

Acadia Healthcare (ACHC) reported Q3 revenue guidance of $3.44B-$3.46B, adjusted EBITDA of $615M-$625M, and adjusted EPS of $1.70-$1.80. The company lowered its full-year capital expenditure forecast to $210M-$230M. It added 220 licensed beds in Q3, with plans for further facility expansions. Medicaid work requirements and legal expenses were discussed, with minimal expected impact. ACHC operates behavioral healthcare facilities in the U.S. and U.K.

$ACHCHigh

Acadia Healthcare: Q3 Earnings Snapshot

Acadia Healthcare (ACHC) reported Q3 earnings of $34.5M, or 38 cents per share, beating estimates of 46 cents. Revenue was $895.3M, exceeding forecasts of $869.3M. The company expects full-year earnings of $1.70-$1.80 per share and revenue of $3.44B-$3.46B. Shares have risen 56% in the past year.